WO2023104707 - SYSTEM AND METHOD FOR MONITORING CRITICAL PHARMACEUTICAL OPERATIONS
National phase entry:
Publication Number
WO/2023/104707
Publication Date
15.06.2023
International Application No.
PCT/EP2022/084391
International Filing Date
05.12.2022
Title **
[English]
SYSTEM AND METHOD FOR MONITORING CRITICAL PHARMACEUTICAL OPERATIONS
[French]
SYSTÈME ET PROCÉDÉ DE SURVEILLANCE D'OPÉRATIONS PHARMACEUTIQUES CRITIQUES
Applicants **
FRESENIUS KABI AUSTRIA GMBH
Hafnerstrasse 36
8055 Graz, AT
Inventors
KÖTH, Christoph
8055 Graz, AT
KLEINHENN, Martin
8101 Gratkorn, AT
KAINZ, Philipp
8010 Graz, AT
MAFFEIS, Andrea
8053 St. Josef, AT
MAYRHOFER-REINHARTSHUBER, Michael
5303 Thalgau, AT
EBNER, Thomas
5760 Saalfelden, AT
EGGER, Christina
8054 Graz, AT
Priority Data
21212628.8
06.12.2021
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1403 | |
| EPO | Filing, Examination | 8132 | |
| Japan | Filing | 591 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 3710 |
Total: 14411 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
A system (1) for monitoring critical pharmaceutical operations comprises an enclosure (10) defining an interior space (100), at least one camera (11) installed so as to record image frames (F) of the interior space (100), and a controller (12), wherein the controller (12) is configured to: receive the image frames (F) recorded by the at least one camera (11), analyse the image frames (F) to detect an event captured by one or more of the image frames (F), using a first model perform a classification of an intervention captured by the one or more of the image frames (F) using a second model (ML 2), the second model (ML 2) being trained with image frames of interventions assigned to at least two different classes, and provide a notification (N) indicating one of the at least two different classes based on the classification.[French]
L'invention concerne un système (1) de surveillance d'opérations pharmaceutiques critiques comprenant une enceinte (10) définissant un espace intérieur (100), au moins une caméra (11) installée de façon à enregistrer des trames d'image (F) de l'espace intérieur (100), et un dispositif de commande (12), le dispositif de commande (12) étant configuré pour : recevoir les trames d'image (F) enregistrées par ladite au moins une caméra (11), analyser les trames d'image (F) pour détecter un événement capturé par une ou plusieurs des trames d'image (F), à l'aide d'un premier modèle, réaliser une classification d'une intervention capturée par la ou les trames d'image (F) à l'aide d'un second modèle (ML2), le second modèle (ML2) étant entraîné avec des trames d'image d'interventions attribuées à au moins deux classes différentes, et fournir une notification (N) indiquant l'une desdites au moins deux classes différentes sur la base de la classification.